More on CAH

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+15.9% Growth)
- Ratings (6.3 Score)
- Holders
- Dividends (0.9% Yield)
- Event Driven Deals

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (8/11/26)
- M&A (12/31/15 *Est)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

CAH Cash Flow Statement

Click line-items for a historical chart and %
Net earnings
(Earnings)/loss from discontinued operations
Earnings from continuing operations
Depreciation and amortization
Loss on extinguishment of debt
Gain on sale of investment in CareFusion
Impairments and loss on sale of assets
Share-based compensation 23M
Provision for deferred income taxes
Provision for bad debts 7M
Decrease/(increase) in trade receivables -306M
Decrease/(increase) in inventories -298M
Increase/(decrease) in accounts payable 279M
Other accrued liabilities and operating items, net -87M
Net cash provided by operating activities-continuing operations
Net cash provided by/(used in) operating activities-discontinued operations
Net cash provided by operating activities 104M
Proceeds from divestitures and sale of property and equipment
Acquisition of subsidiaries, net of cash acquired -9M
Purchase of held-to-maturity investment securities
Additions to property and equipment -100M
Proceeds from sale of CareFusion common stock
Proceeds from maturities of held-to-maturity securities
Net cash provided by/(used in) investing activities-continuing operations
Net cash used in investing activities-discontinued operations
Net cash provided by/(used in) investing activities -110M
Payment of contingent consideration 0
Net change in short-term borrowings
Reduction of long-term obligations -1M
Proceeds from long-term obligations, net of issuance costs
Proceeds from issuance of Common Shares
Tax disbursements from exercises of stock options 30M
Payment of premiums for debt extinguishment
Dividends on Common Shares -149M
Purchase of treasury shares -250M
Net cash used in financing activities-continuing operations
Net cash provided by/(used in) financing activities-discontinued operations
Net cash used in financing activities -350M
NET INCREASE/(DECREASE) IN CASH AND EQUIVALENTS -355M
CASH AND EQUIVALENTS AT BEGINNING OF YEAR 2.36B
CASH AND EQUIVALENTS AT END OF YEAR 2B
Interest
Income taxes
Retained investment in CareFusion at date of Spin-Off
Non-cash dividend in connection with Spin-Off